Sunnova Energy International Inc. ( NYSE: NOVA) Q4 2024 Earnings Conference Call March 3, 2025 6:00 AM ET Rodney McMahan - Vice President of Investor Relations John Berger - Chairman & Chief Executive Officer Eric Williams - Executive Vice President & Chief Financial Officer Paul Mathews - Chief Operating Officer

For the current quarter ending in March, Emergent Biosolutions said it expects revenue in the range of $200 million to $240 million. This story was generated by Automated Insights ( using data from Zacks Investment Research.

Adma Biologics shares have fallen roughly 8% since the beginning of the year. In the final minutes of trading on Monday, shares hit $15.83, nearly tripling in the last 12 months. This story was generated by Automated Insights ( using data from Zacks Investment Research.